Thompson Andy
PO Box 5777, Station B, London, Ontario N6A 4V2.
J Rheumatol Suppl. 2009 Jun;82:39-41. doi: 10.3899/jrheum.090130.
With the availability of more effective treatments for the management of rheumatoid arthritis (RA), patients look to their rheumatologist to guide their decision-making. The challenge for rheumatologists is to effectively communicate the risks and benefits related to the many options that are currently available for patients with RA. Physicians must be aware of patient preferences regarding the administration and dosing of their RA medications to help guide their treatment decisions.
随着类风湿性关节炎（RA）管理方面有了更有效的治疗方法，患者期望他们的风湿病专家来指导其决策。风湿病专家面临的挑战是，要有效地传达与目前RA患者可用的众多选择相关的风险和益处。医生必须了解患者对RA药物给药方式和剂量的偏好，以帮助指导治疗决策。
